A study evaluating efficacy of Ramelteon for treatment of elderly patients with delirium in general hospital setting.

Trial Profile

A study evaluating efficacy of Ramelteon for treatment of elderly patients with delirium in general hospital setting.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Sep 2017

At a glance

  • Drugs Ramelteon (Primary)
  • Indications Delirium
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Sep 2017 New trial record
    • 20 Sep 2017 Primary endpoint (Decrease in need for PRN antipsychotics) has been met as per the results published in the Clinical Drug Investigation
    • 20 Sep 2017 Results published in the Clinical Drug Investigation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top